标题
Narrow-spectrum antibacterial agents
作者
关键词
-
出版物
MedChemComm
Volume 9, Issue 1, Pages 12-21
出版商
Royal Society of Chemistry (RSC)
发表日期
2017-11-06
DOI
10.1039/c7md00528h
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
- (2017) Travis B Nielsen et al. JOURNAL OF INFECTIOUS DISEASES
- Reducing global tuberculosis deaths—time for India to step up
- (2017) Madhukar Pai et al. LANCET
- A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail
- (2017) Debra A Goff et al. LANCET INFECTIOUS DISEASES
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
- (2017) Richard J Vickers et al. LANCET INFECTIOUS DISEASES
- Targeted antimicrobial therapy in the microbiome era
- (2017) V.N. Stone et al. Molecular Oral Microbiology
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- 6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
- (2017) Amy S. T. Tong et al. ACS Medicinal Chemistry Letters
- Antibiotic exposure perturbs the gut microbiota and elevates mortality in honeybees
- (2017) Kasie Raymann et al. PLOS BIOLOGY
- Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors
- (2017) Ursula Waack et al. Frontiers in Cellular and Infection Microbiology
- The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
- (2017) Roberta J. Melander et al. ACS Infectious Diseases
- Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae — Washoe County, Nevada, 2016
- (2017) Lei Chen et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression
- (2017) Giulia Degiacomi et al. Scientific Reports
- Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids
- (2017) Lisa M. Leung et al. Scientific Reports
- Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
- (2017) Matthew F. Wipperman et al. Scientific Reports
- New agents for the treatment of drug-resistant Mycobacterium tuberculosis
- (2016) Daniel T. Hoagland et al. ADVANCED DRUG DELIVERY REVIEWS
- Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections
- (2016) James M. Regeimbal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii
- (2016) Mya Thandar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults
- (2016) Xiang-Qing Yu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ridinilazole: a novel therapy for Clostridium difficile infection
- (2016) Richard J. Vickers et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics
- (2016) Tucker Maxson et al. TETRAHEDRON
- Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
- (2016) Subramanyam J. Tantry et al. MedChemComm
- 1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant Acinetobacter baumannii
- (2016) William M. Huggins et al. ACS Medicinal Chemistry Letters
- Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficileCompounds Fidaxomicin and LFF571
- (2016) Jennifer A. Leeds Cold Spring Harbor Perspectives in Medicine
- The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation
- (2016) Amy Langdon et al. Genome Medicine
- Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options
- (2016) S.M. Purrello et al. Journal of Global Antimicrobial Resistance
- 1,2,4-Triazolidine-3-thiones Have Specific Activity against Acinetobacter baumannii among Common Nosocomial Pathogens
- (2016) Brendan W. Corey et al. ACS Infectious Diseases
- A multi-center study of fidaxomicin use for Clostridium difficile infection
- (2016) Dhara N. Shah et al. SpringerPlus
- Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood
- (2015) O. Opota et al. CLINICAL MICROBIOLOGY AND INFECTION
- The effect of past antibiotic exposure on diabetes risk
- (2015) B. Boursi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Antibiotics: the changing regulatory and pharmaceutical industry paradigm
- (2015) Richard Bax et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synthesis and Evaluation of 1,2,4-Triazolo[1,5-a]pyrimidines as Antibacterial Agents Against Enterococcus faecium
- (2015) Huan Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- ESKAPEing the labyrinth of antibacterial discovery
- (2015) Ruben Tommasi et al. NATURE REVIEWS DRUG DISCOVERY
- Risks of Antibiotic Exposures Early in Life on the Developing Microbiome
- (2015) Anjelique Schulfer et al. PLoS Pathogens
- Survey of Physicians’ Perspectives and Knowledge about Diagnostic Tests for Bloodstream Infections
- (2015) Rosemary C. She et al. PLoS One
- The evolution of the regulatory framework for antibacterial agents
- (2014) John H. Rex et al. Annals of the New York Academy of Sciences
- Design and recombination expression of a novel plectasin-derived peptide MP1106 and its properties against Staphylococcus aureus
- (2014) Xintao Cao et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Antibiotic Adjuvants: Diverse Strategies for Controlling Drug-Resistant Pathogens
- (2014) Erin E. Gill et al. Chemical Biology & Drug Design
- MALDI-TOF MS for the Diagnosis of Infectious Diseases
- (2014) R. Patel CLINICAL CHEMISTRY
- Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*
- (2014) Hao-Yuan Lee et al. CRITICAL CARE MEDICINE
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- FDA Approval of Bedaquiline — The Benefit–Risk Balance for Drug-Resistant Tuberculosis
- (2014) Edward Cox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal bacteria protect against food allergen sensitization
- (2014) A. T. Stefka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
- (2014) A. DiGiandomenico et al. Science Translational Medicine
- Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043
- (2014) Rohit Tiwari et al. ACS Medicinal Chemistry Letters
- O serotype-independent susceptibility ofPseudomonas aeruginosato lectin-like pyocins
- (2014) Maarten G. K. Ghequire et al. MicrobiologyOpen
- ComparativeIn VitroActivities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates
- (2013) Ellie J. C. Goldstein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
- (2013) A. M. Caliendo et al. CLINICAL INFECTIOUS DISEASES
- Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection
- (2013) M. C. Rea et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2013) Oluseye K. Onajole et al. JOURNAL OF MEDICINAL CHEMISTRY
- The value of single-pathogen antibacterial agents
- (2013) Brad Spellberg et al. NATURE REVIEWS DRUG DISCOVERY
- Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- Local resistance patterns to antimicrobials in internal medicine: a focused report from the REGIMEN (REGistro Infezioni in MEdicina INterna) study
- (2012) Marco Cei et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Bacteriocins — a viable alternative to antibiotics?
- (2012) Paul D. Cotter et al. NATURE REVIEWS MICROBIOLOGY
- Antibiotics, microbiota, and immune defense
- (2012) Carles Ubeda et al. TRENDS IN IMMUNOLOGY
- Intrinsic and acquired resistance mechanisms in enterococcus
- (2012) Brian L. Hollenbeck et al. Virulence
- Rapid Diagnostics and Appropriate Antibiotic Use
- (2011) Louis B. Rice CLINICAL INFECTIOUS DISEASES
- Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
- (2011) V. Stevens et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Activity of Fidaxomicin (OPT-80) Tested against Contemporary Clinical Isolates of Staphylococcus spp. and Enterococcus spp.
- (2010) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A predicted S-type pyocin shows a bactericidal activity against clinicalPseudomonas aeruginosaisolates through membrane damage
- (2010) Hua Ling et al. FEBS LETTERS
- Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
- (2010) T. Schneider et al. SCIENCE
- The case for pathogen-specific therapy
- (2009) Arturo Casadevall EXPERT OPINION ON PHARMACOTHERAPY
- What are the consequences of the disappearing human microbiota?
- (2009) Martin J. Blaser et al. NATURE REVIEWS MICROBIOLOGY
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
- (2008) Louis B. Rice JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started